Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

/PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of...

Related Keywords

Washington ,United States ,Saar Gill ,Joseph Fraietta ,Vanessa Almendro ,Megan Suhoski ,Friederike Herbst Nowrouzi ,University Of Pennsylvania Penn ,Product Development Laboratory ,Technology Innovation ,Human Genome Editing Laboratory ,Prnewswire Danaher Corporation ,Drug Administration ,University Of Pennsylvania ,Cell Therapy Innovation ,Danaher Beacons ,Product Development ,Danaher Corporation ,